Zentalis Pharmaceuticals Provides Update on Azenosertib Clinical Development Program

Go back to Zentalis Pharmaceuticals Provides Update on Azenosertib Clinical Development Program
(NASDAQ: ZNTL) Delayed: 2.13 -0.11 (4.91%)
Previous Close $2.24    52 Week High $ 
Open $2.25    52 Week Low $ 
Day High $2.30    P/E N/A 
Day Low $2.10    EPS $ 
Volume 1,101,802